Unusually Elevated Serum Insulin Level in a Diabetic Patient during Recombinant Insulin Therapy
Laboratory Medicine Online
;
: 56-59, 2013.
Article
in Korean
| WPRIM
| ID: wpr-170608
ABSTRACT
Herein, we report a case of unusually elevated serum insulin level as a result of increased anti-insulin antibody (IA)-bound insulin after continuous subcutaneous insulin infusion therapy. Detecting free insulin (unbound IAs) levels after polyethylene glycol pre-treatment could be useful to assess functional insulin levels in diabetic patients receiving insulin therapy. The E170 insulin assay can estimate total insulin (bound IAs and free insulin) levels, but it does not measure the levels of exogenous insulin analogues.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Polyethylene Glycols
/
Insulin
/
Insulin Antibodies
Limits:
Humans
Language:
Korean
Journal:
Laboratory Medicine Online
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS